⁠Industries – Parker Lloyd

Areas of Focus

We target high-growth sectors where our capital and strategic consulting can drive market disruption and long-term asset appreciation.

Healthcare

Revolutionizing Patient Care & Delivery

The Strategy: We do not merely invest; we partner with companies fundamentally reshaping the healthcare ecosystem. Our approach leverages deep industry expertise and thorough analysis to identify assets with robust management teams and clear visions for the future.

Key Segments:

Strategic Scope: Pharmaceuticals, Hospital Management, Health Policy, and Medical Devices Consulting.
Value Creation: We focus on scaling innovative products and optimizing healthcare delivery systems to generate sustainable financial returns while improving global health outcomes.

Technology

Capitalizing on Disruption

The Strategy: Innovation is the primary driver of our alpha. We provide the capital, resources, and strategic guidance necessary for visionary entrepreneurs to push the boundaries of what is possible.

Key Segments:

Emerging Frontiers: Artificial Intelligence, Blockchain, Cybersecurity, and the Internet of Things (IoT).
Hardware & Software: From groundbreaking software solutions to cutting-edge hardware, we target investments that disrupt markets and create lasting value.

Real Estate

Building Opportunities, Shaping Skylines

The Strategy: We utilize a keen understanding of market trends to execute specific strategies in both residential and commercial real estate. Our goal is long-term growth through the entire lifecycle of the asset, from concept to completion.

Key Segments:

Development: Revitalizing urban neighborhoods, creating vibrant mixed-use developments, and entering high-growth markets.
Portfolio: A diverse mix of urban developments and stable suburban communities.

Click outside to hide the comparison bar

Compare

Dr. Ravi Kallur, PhD, MPA, serves as a Senior Consultant at Parker Lloyd, where he delivers specialized expertise in graduate medical education (GME), undergraduate medical education (UME), institutional accreditation, and strategic development for healthcare organizations and academic partners. In addition, Dr. Kallur currently acts as a Senior Advisor to Prime Healthcare, providing high-level counsel on medical education initiatives, program expansion, and regulatory compliance within the system's network of hospitals and facilities.

With more than 20 years of executive leadership in medical education, Dr. Kallur has successfully developed and secured accreditation for over 35 new residency and fellowship programs under the Accreditation Council for Graduate Medical Education (ACGME). His notable achievements include establishing sponsoring institutions with initial accreditation, obtaining ACGME initial accreditation for multiple residency programs, and managing the seamless transition of large GME portfolios encompassing hundreds of residents and fellows across hospital systems. He has consistently optimized operations to enhance funding opportunities, including CMS reimbursement and state-designated statutory teaching hospital status, which have collectively generated millions in additional resources.

Since 2022, in his consulting capacity, Dr. Kallur has established two sponsoring institutions with initial accreditation, secured initial ACGME accreditation for five residency programs, and supported the transition of 10 GME programs involving 200 residents and fellows. Previously, as Division Vice President and Designated Institutional Official (DIO) at HCA, he managed budgets exceeding $50 million, achieved statutory teaching hospital designations that yielded substantial state funding (including $9 million for two hospitals), and oversaw the accreditation of numerous new programs. He also served as a primary liaison with medical schools such as Nova Southeastern University and Florida International University, while hiring key academic leadership and managing extensive teams.

In his earlier role as Senior Vice President and DIO at Baylor Scott & White Health, Dr. Kallur reduced unfunded resident positions through strategic VA partnerships, secured multimillion-dollar grants from the Texas Higher Education Coordinating Board, and led departmental integrations following institutional mergers. At Children's Mercy Hospital, he contributed to the launch of 12 new pediatric fellowships and served as a key liaison for international faculty recruitment and consortium finance.

Dr. Kallur holds a PhD in Higher Education Administration and a Master of Public Administration (with a focus on Health Administration) from the University of Missouri-Kansas City. He maintains active memberships in the Association of American Medical Colleges (AAMC) and the Accreditation Council for Graduate Medical Education (ACGME). His academic appointments include Affiliate Associate Professor and Affiliate Associate Dean at Nova Southeastern University's Dr. Kiran C. Patel College of Allopathic Medicine and Florida International University's Herbert Wertheim College of Medicine, among others.

Dr. Kallur's proficiency spans strategic planning, budget management, faculty and staff recruitment, accreditation compliance (ACGME and LCME), process optimization, and the cultivation of effective partnerships between health systems and educational institutions. He remains dedicated to advancing superior medical education standards that improve patient outcomes, institutional efficiency, and long-term organizational success.

Mr. Michael Mark serves as a Senior Consulting Partner at Parker Lloyd, where he provides strategic leadership and advisory services to healthcare organizations, focusing on start-up ventures, turnaround initiatives, managed care operations, and technology-driven solutions in the healthcare sector.

With more than 40 years of senior executive experience in the healthcare industry, Mr. Mark has established himself as a proven leader in profit-and-loss management, organizational restructuring, and revenue growth for health plans, provider organizations, and technology firms. He has served as President and CEO of several managed care entities, including Blue Care Network, Health Plus, Methodist Memphis PHO, and DMC Care, where he was responsible for annual revenues totaling approximately $3.4 billion and the management of more than 3,300 employees.

In his technology leadership roles, Mr. Mark held senior positions at Science Applications International Corporation (SAIC), Computer Sciences Corporation (CSC), and Superior Consultant. At CSC, he directed the comprehensive restructuring of sales, information technology operations, and service delivery organizations, incorporating offerings such as data center operations, claims transaction adjudication, business solution centers, back-room operations, and process improvement. This included managing Business Process Outsourcing for New York State Medicaid. During his tenure at SAIC, he led the development of a broad portfolio of healthcare services and supported Kaiser Permanente’s implementation of the Epic electronic medical record system. He also collaborated with high-level federal officials, including the retired Assistant Secretary of Defense for Health Affairs and the retired Surgeons General of the Army, Navy, and Air Force, to advance solutions for the Military Health System (MHS), Centers for Medicare and Medicaid Services (CMS), Tricare, and the Centers for Disease Control and Prevention.

Mr. Mark excels in guiding small to medium-sized healthcare businesses toward achieving market positioning, operational efficiency, and revenue objectives. His expertise encompasses strategic planning, executive leadership, process optimization, and the integration of technology with healthcare delivery to drive sustainable performance and organizational success. At Parker Lloyd, he applies this extensive background to assist clients in navigating complex healthcare challenges, enhancing competitive positioning, and realizing long-term strategic goals.

Dr. Joseph M. Chalil serves as Managing Partner of Parker Lloyd, where he leads the firm’s U.S. operations and provides high-level strategic advisory and investment guidance in life sciences, healthcare technology, diagnostics, and global healthcare infrastructure. In addition, Dr. Chalil serves as Chief Medical Advisor at Geneva Private Equity, where he offers expert medical and scientific counsel on investment strategies and portfolio companies in the healthcare and life sciences sectors.

A strategic clinical and business leader with over 26 years of global experience in the pharmaceutical, biotechnology, and healthcare sectors, Dr. Chalil has held senior leadership positions at major pharmaceutical companies, including Abbott, Hoffmann-La Roche, Boehringer Ingelheim, and DBV Technologies.

Since joining Parker Lloyd in 2025, Dr. Chalil has advised foreign healthcare and diagnostics companies on U.S. market entry, including 510(k) and De Novo submissions, CLIA waiver strategies, clinical trial design, ISO 13485/MDSAP compliance, and commercial launches. He also guides U.S. corporations on expansion into APAC, MENA, and EU markets through joint ventures, licensing, and distribution agreements, unlocking significant pipeline value.

An accomplished inventor, Dr. Chalil holds seven U.S. and international patents in CMOS-MEMS hybrid integrated technologies. He is the bestselling author of two influential books on global healthcare transformation: India Beyond the Pandemic: A Sustainable Path Towards Global Quality Healthcare (2024) and Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare (2020). Recognized as a World-Class Media Influencer, he regularly authors op-eds and white papers on healthcare policy, innovation, and market-driven regulations for global access.

Dr. Chalil serves as Advisor to the Ministry of Health in the Government of India. He is a U.S. Navy Medical Corps veteran and Fellow of the American College of Healthcare Executives (FACHE). He holds academic appointments at Nova Southeastern University, including Adjunct Professor and Chair of the Complex Health Systems Advisory Board at the H. Wayne Huizenga College of Business & Entrepreneurship, and Advisory Board Member at the Ron and Kathy Assaf College of Nursing. He is also pursuing an LLM in Medical Law and Ethics at the University of Edinburgh Law School.

Dr. Chalil combines deep clinical expertise, pharmaceutical industry leadership, regulatory acumen, and strategic vision to help organizations navigate complex global healthcare environments, forge transformative partnerships, and deliver innovative, patient-centered solutions worldwide.